Universal Health Gets a Buy Rating from RBC Capital

By Austin Angelo

In a report issued on August 27, Frank Morgan from RBC Capital reiterated a Buy rating on Universal Health (NYSE: UHS), with a price target of $147. The company’s shares closed yesterday at $109.07.

According to TipRanks.com, Morgan is a 5-star analyst with an average return of 9.5% and a 56.3% success rate. Morgan covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, Fresenius Medical Care Corp, and Quest Diagnostics Inc.

Universal Health has an analyst consensus of Strong Buy, with a price target consensus of $137.

Universal Health’s market cap is currently $10.43B and has a P/E ratio of 14.84. The company has a book value ratio of 2.1678.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Universal Health Services, Inc. operates as a healthcare management company, which through its subsidiaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers. It operates through the Acute Care Hospital Services and Behavioral Health Care Services segments.